Dow Jones

39 112,16

-0,76%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

WX

(WX)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:WX

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/03/2019	17h00	Business Wire	IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Caym...	NYSE:WX
02/03/2019	00h32	Business Wire	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Cayman)...	NYSE:WX
31/08/2017	23h27	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NYSE:WX
22/09/2016	14h00	PR Newswire (US)	WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreacto...	NYSE:WX
27/04/2016	10h18	PR Newswire (US)	LabNetwork Forges eCommerce Alliances with Leading Chemical Providers	NYSE:WX
10/02/2016	16h56	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:WX
11/01/2016	16h37	Edgar (US Regulatory)	Schedule 13g (sc 13g/a)	NYSE:WX
16/12/2015	08h40	PR Newswire (US)	WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China	NYSE:WX
14/12/2015	00h00	PR Newswire (US)	WuXi PharmaTech Presents 2015 Life Science and Chemistry Awards	NYSE:WX
11/12/2015	20h10	Edgar (US Regulatory)	(25-NSE)	NYSE:WX
10/12/2015	23h14	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NYSE:WX
10/12/2015	23h02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:WX
10/12/2015	22h49	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NYSE:WX
10/12/2015	22h45	PR Newswire (US)	WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction	NYSE:WX
08/12/2015	01h00	GlobeNewswire Inc.	WuXi PharmaTech and PRA Health Sciences Restructure Relationship in China	NYSE:WX
07/12/2015	14h00	PR Newswire (US)	Dr. Ge Li Receives Executive of the Year Award from SCRIP	NYSE:WX
01/12/2015	15h50	Dow Jones News	China's Qihoo 360 Moving Closer to $9 Billion Buyout	NYSE:WX
25/11/2015	04h00	PR Newswire (US)	WuXi PharmaTech Announces Shareholders' Approval of Merger Agreement	NYSE:WX
12/11/2015	10h37	PR Newswire (US)	Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and Cancer	NYSE:WX
11/11/2015	18h01	PR Newswire (US)	ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction	NYSE:WX
10/11/2015	22h30	PR Newswire (US)	WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China	NYSE:WX
09/11/2015	14h00	GlobeNewswire Inc.	Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing Capacity	NYSE:WX
05/11/2015	21h17	PR Newswire (US)	WuXi PharmaTech Congratulates Novira Therapeutics	NYSE:WX
03/11/2015	22h05	PR Newswire (US)	WuXi PharmaTech Announces Third-Quarter 2015 Results	NYSE:WX
03/11/2015	12h00	PR Newswire (US)	Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project	NYSE:WX
30/10/2015	03h00	PR Newswire (US)	Gilead Sciences and WuXi PharmaTech Announce Collaboration for a Dedicated Analytical and Stability Testing Facility	NYSE:WX
20/10/2015	16h00	PR Newswire (US)	WuXi PharmaTech (Cayman) Inc. Announces Extraordinary General Meeting of Shareholders	NYSE:WX
19/10/2015	14h00	PR Newswire (US)	Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi AppTec Headquarters in Shanghai	NYSE:WX
16/10/2015	14h00	PR Newswire (US)	WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan	NYSE:WX
13/10/2015	14h00	PR Newswire (US)	WuXi PharmaTech Launches Mobile OncoWuXi, the World's First App for Accessing Oncology Models	NYSE:WX